The original text
BioMarin也迅速跟进迭代研发，其升级版在研产品BMN333同样旨在实现周剂注射。早期临床结果显示BMN333的AUC水平高于其他长效CNP研究的3倍以上，公司研发主管Greg Friberg表示该药对标的正是TransCon-CNP。
，详情可参考heLLoword翻译官方下载
This isn't the first time the fintech company has made deep cuts in its employee count. Layoffs numbering about 1,000 were rumored both in 2024 and 2025.
The 4732 had a generally upgraded interface, including a CRT, but a similar
�o�T�FNeoclouds size up enterprise opportunities�iCIO Dive�j��1�FRegulatory risks push cloud leaders to alter infrastructure plans�iCIO Dive�j��2�FNeoclouds helped drive Q3 cloud market surge�iChannel Dive�j��3�F4 tips for evaluating cloud AI providers�iCIO Dive�j��4�FTen Trends That Shaped the Cloud Market in 2024�iIDC�j��5�FThe evolution of neoclouds and their next moves�iMckinsey & Company�j��6�FCoreWeave Expands Agreement with OpenAI by up to $6.�iCoreWeave�j��7�F5 channel trends for 2026�iChannel Dive�j